TELA Bio, Inc. Proceeds from Sale of Productive Assets
TELA Bio, Inc. (TELA) reported Proceeds from Sale of Productive Assets of $607.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2026-08-11
- TELA Bio, Inc. proceeds from sale of productive assets for the quarter ending 2026-06-30 was $298.00K, a 6.29% decline year-over-year.
- TELA Bio, Inc. proceeds from sale of productive assets for the quarter ending 2026-03-31 was $309.00K, a 81.76% increase year-over-year.
- TELA Bio, Inc. proceeds from sale of productive assets for the quarter ending 2025-12-31 was $283.00K, a 282.43% increase year-over-year.
- TELA Bio, Inc. proceeds from sale of productive assets for the quarter ending 2025-09-30 was $523.00K.
- TELA Bio, Inc. proceeds from sale of productive assets for fiscal 2025 was $1.29M, a 76.21% decline from fiscal 2024.
- TELA Bio, Inc. proceeds from sale of productive assets for fiscal 2024 was $5.44M.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $298.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $607.00K 10-Q · filed 2026-08-11 | $890.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.41M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $309.00K 10-Q · filed 2026-05-13 | $592.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.11M derived: sum of 3 quarters · filed 2026-05-13 | $1.43M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $283.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $806.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.12M derived: sum of 3 quarters · filed 2026-08-11 | $1.29M 10-K · filed 2026-03-25 |
| 2025-09-30 | $523.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $841.00K derived: sum of 2 quarters · filed 2026-08-11 | $1.01M 10-Q · filed 2025-11-14 | $1.08M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $318.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $488.00K 10-Q · filed 2026-08-11 | $562.00K derived: sum of 3 quarters · filed 2026-08-11 | $562.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $170.00K 10-Q · filed 2026-05-13 | $244.00K derived: sum of 2 quarters · filed 2026-05-13 | $244.00K derived: sum of 3 quarters · filed 2026-05-13 | $610.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $74.00K derived: sum of 2 quarters · filed 2026-03-25 | $440.00K derived: sum of 3 quarters · filed 2026-03-25 | $5.44M 10-K · filed 2026-03-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $366.00K derived: sum of 2 quarters · filed 2025-11-14 | $5.37M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $366.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $5.37M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $5.00M 10-Q · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |